Suppr超能文献

相似文献

1
The loss of tuberin promotes cell invasion through the ß-catenin pathway.
Am J Respir Cell Mol Biol. 2010 Nov;43(5):617-27. doi: 10.1165/rcmb.2008-0335OC. Epub 2009 Dec 30.
4
The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
Histopathology. 2002 May;40(5):458-63. doi: 10.1046/j.1365-2559.2002.01394.x.
5
Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.
Am J Pathol. 2010 Oct;177(4):1765-78. doi: 10.2353/ajpath.2010.090233. Epub 2010 Sep 2.
7
The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
J Biol Chem. 2003 Feb 21;278(8):5947-51. doi: 10.1074/jbc.C200473200. Epub 2003 Jan 2.
10
Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
J Biol Chem. 2017 Dec 15;292(50):20528-20543. doi: 10.1074/jbc.M117.799593. Epub 2017 Sep 27.

引用本文的文献

1
Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells.
Biomedicines. 2021 Nov 24;9(12):1760. doi: 10.3390/biomedicines9121760.
3
CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis.
Int J Mol Sci. 2021 Feb 24;22(5):2233. doi: 10.3390/ijms22052233.
4
mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division.
Nat Commun. 2020 Jun 24;11(1):3200. doi: 10.1038/s41467-020-16978-z.
5
Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment.
Onco Targets Ther. 2018 Aug 31;11:5339-5347. doi: 10.2147/OTT.S161360. eCollection 2018.
6
promotes kidney cancer OS-RC-2 cells proliferation and invasion and .
Asian J Urol. 2015 Jul;2(3):151-157. doi: 10.1016/j.ajur.2015.06.009. Epub 2015 Jul 18.
8
CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.
Chest. 2018 Feb;153(2):339-348. doi: 10.1016/j.chest.2017.05.018. Epub 2017 May 30.
9
Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.
Annu Rev Med. 2017 Jan 14;68:69-83. doi: 10.1146/annurev-med-050715-104245.
10
EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.
Expert Opin Orphan Drugs. 2016;4(4):369-378. doi: 10.1517/21678707.2016.1148597. Epub 2016 Mar 7.

本文引用的文献

1
Analysis of cell proliferation and cell survival by continuous BrdU labeling and multivariate flow cytometry.
Curr Protoc Cytom. 2001 May;Chapter 7:Unit 7.14. doi: 10.1002/0471142956.cy0714s15.
2
Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity.
Am J Pathol. 2008 May;172(5):1256-70. doi: 10.2353/ajpath.2008.070891. Epub 2008 Apr 1.
4
Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
Hum Pathol. 2007 Sep;38(9):1361-71. doi: 10.1016/j.humpath.2007.01.028. Epub 2007 May 22.
5
Wnt/beta-catenin signaling in development and disease.
Cell. 2006 Nov 3;127(3):469-80. doi: 10.1016/j.cell.2006.10.018.
6
Matrix metalloproteinases in development and disease.
Birth Defects Res C Embryo Today. 2006 Mar;78(1):1-10. doi: 10.1002/bdrc.20065.
7
Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.
Am J Respir Cell Mol Biol. 2006 Apr;34(4):473-80. doi: 10.1165/rcmb.2005-0374OC. Epub 2005 Dec 30.
8
Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis.
Exp Biol Med (Maywood). 2006 Jan;231(1):20-7. doi: 10.1177/153537020623100103.
9
Aberrant beta-catenin signaling in tuberous sclerosis.
Am J Pathol. 2005 Jul;167(1):107-16. doi: 10.1016/s0002-9440(10)62958-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验